Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic role of genetic biomarkers in clinical progression of prostate cancer.

Experimental & molecular medicine - 7 Aug 2015

Alvarez-Cubero Maria Jesus, Martinez-Gonzalez Luis Javier, Saiz Maria, Carmona-Saez Pedro, Alvarez Juan Carlos, Pascual-Geler Manrique, Lorente Jose Antonio, Cozar Jose Manuel

Abstract excerpt

The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients. A cohort of 451 men (235 patients and 216 controls) was studied. We calculated means of regression analysis using clinical values (stage, prostate-specific antigen,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Disease Progression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Endoribonucleases

Share to Genetic Markers

Share to Neoplasm Proteins

Share to Prostate

Share to Prostatic Neoplasms

Share to Scavenger Receptors, Class A

Source

Open in PubMed Open full text

Identifiers

PMID: 26251261
DOI: 10.1038/emm.2015.43
PMCID: PMC4558485

Genes

ELAC2
MSR1
RNASEL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic role of genetic biomarkers in clinical progression of prostate cancer.PMID 26251261Read ↗

Genetic analysis of the principal genes related to prostate cancer: a review.Semantic proximity Read ↗

Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer.Semantic proximity Read ↗

Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.Semantic proximity Read ↗

[RNASEL study of genetics of prostate cancer and its relation to clinical staging].Semantic proximity Read ↗

Evidence from 40 Studies that 2 Common Single-Nucleotide Polymorphisms (SNPs) of RNASEL Gene Affect Prostate Cancer Susceptibility: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-Compliant Meta-Analysis.Semantic proximity Read ↗

Single Nucleotide Polymorphisms Associated with Prostate Cancer Progression: A Systematic Review.Semantic proximity Read ↗

A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.Semantic proximity Read ↗

Genetic determinants of prostate cancer: a review.Semantic proximity Read ↗

Genetic predisposition to early recurrence in clinically localized prostate cancer.Semantic proximity Read ↗

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Semantic proximity Read ↗

Perspective: prostate cancer susceptibility genes.Semantic proximity Read ↗

Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a Hispanic population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.